RCT characterizing rapamycin pharmacokinetics and pharmacodynamics in older adults
This was a randomized controlled trial designed to characterize how rapamycin is processed and acts in the body in older adults. The study aimed to generate foundational pharmacokinetic and pharmacodynamic data needed to inform future clinical trials of mTOR inhibitors in aging-related conditions. No efficacy outcomes, sample sizes, or effect sizes were reported in the available material.
What this changes
The finding has not established an approved change to our evidence assessment.
Source date: Jun 25, 2026 · Discovered: Sep 18, 2026 · Assessed: — · Research update
What it does not prove
- Limitations have not yet been verified. Read the primary source.
Extracted from supplied source material; model confidence is not a measured probability of correctness.
Study details
- Design
- Rct
- Sample size
- —
- Duration
- —
- Population
- —
- Primary outcome
- —
- Effect size
- —
- Significance
- Not reported
- Journal
- University of Texas Southwestern Medical Center
- Published
- Jun 25, 2026
Sources
Primary source
- University of Texas Southwestern Medical Center ↗Clinical trial
Source versions
Assessment history
9/23/2026 · SUPERSEDED: Source updated; assessment withdrawn pending review.
Discussion (0)
One thread per scientific event, no matter how many outlets covered it.
No comments yet
Be the first to weigh in on this evidence.